LC
LMAT icon

Lavaca Capital’s LeMaitre Vascular LMAT Stock Holding History

Lavaca Capital’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.91K Buy
+72
New +$7.38K ﹤0.01% 325

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Lavaca Capital's LMAT Position: Q2 2026 in Review

Lavaca Capital opened a new position in LeMaitre Vascular (LMAT) in Q2 2026: 72 shares worth $6.91K. The stake represents ﹤0.01% of the portfolio and ranks #325 among its holdings.

326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Lavaca Capital held 72 shares of LeMaitre Vascular worth $6.91K as of Q2 2026.
  • LeMaitre Vascular was a new Lavaca Capital position in Q2 2026.
  • LeMaitre Vascular made up ﹤0.01% of Lavaca Capital's portfolio in Q2 2026, its #325 holding.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Lavaca Capital's 13F filing for Q2 2026, filed 14 Aug 2026.